Name: Cardiovascular Aging Research & Development (CARD) Symposium
Start: 2027-05-06T15:00:00.000-04:00
End: 2027-05-06T19:00:00.000-04:00
Location: Boston, MA

Connecting Boston's aging research community

Aging Initiative

The Cardiovascular Aging Research & Development (CARD) Symposium brings together leaders across biotechnology, medicine, and academia to discuss the next generation of cardiovascular therapeutics: from emerging clinical trials and precision cardiology to the molecular mechanisms driving cardiometabolic disease.

 (Founding CEO of Alnylam; Co-CEO of Corsera Health), 

 (CEO of Verve Therapeutics; EVP at Eli Lilly), 

 (Brigham and Women's Hospital / TIMI Study Group), and 

 (CEO of NewAmsterdam Pharma) will be joining us as featured speakers at CARD.

Scientific sessions will explore topics ranging from AI-driven cardiovascular data analysis and precision medicine to Lp(a)-targeted therapeutics, gene editing, cardiometabolic drug development, lipid biology, aldosterone dysregulation, vascular inflammation, and the translation of basic discoveries into new clinical therapies.

Hosted by the Aging Initiative, CARD aims to bridge basic science, translational research, clinical medicine, and biotechnology to accelerate progress against cardiovascular disease, the world's leading cause of death.